Your trusted source for investing success

Tag: genetic research

Liberty Leaf Signs LOI to Acquire 27.5 Percent Interest of GR8 Track

Liberty Leaf Holdings (CSE:LIB) has announced it has entered into a letter of intent (LOI) to acquire a 27.5 percent interest in Gr8 Track, a private corporation in California licensed to produce cannabis for medical use.

William Rascan, president and CEO of Liberty Leaf said:
This LOI which includes a loan provision

AGTC Announces Data Evaluating Novel AAV-Based Gene Therapy as a Potential Treatment for Leber Congenital Amaurosis (LCA) and Severe Early-Childhood-Onset Retinal Degeneration (SECORD)

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 22, 2016 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced data evaluating an experimental recombinant AAV vector gene delivery in patients with

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
What Is Genetics Investing?

URL: https://investingnews.com/daily/life-science-investing/genetics-investing/what-is-genetics-investing/